Startup developing diagnostic test for colon cancer raises $105M By: St. Louis Business Journal via Business Journals November 16, 2021 at 08:06 AM EST The startup's fresh financing comes as it is completing a clinical trial for its diagnostic test designed to detect colon cancer. Read More >> Related Stocks: Innocan Pharma Corp
